Byrne Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Byrne Asset Management's GILD Position: Q2 2026 in Review
Byrne Asset Management reduced its Gilead Sciences (GILD) stake by 0.8% in Q2 2026, selling an estimated $2.63K and leaving 2,485 shares worth $314K. The position accounts for 0.17% of the portfolio, ranked #101.
Byrne Asset Management first reported a position in GILD in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.17M in Q4 2022. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Byrne Asset Management held 2,485 shares of Gilead Sciences worth $314K as of Q2 2026.
- Byrne Asset Management sold 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
- Gilead Sciences made up 0.17% of Byrne Asset Management's portfolio in Q2 2026, its #101 holding.
- Byrne Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 13 quarters since.
- Byrne Asset Management's Gilead Sciences position peaked at $1.17M in Q4 2022.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.